Arena Pharmaceuticals, Inc. (ARNA) Posts Q3 Loss of 16c/Sh.
Tweet Send to a FriendGet Alerts ARNA Hot Sheet
Price: $7.98 -0.25%
Financial Fact:
Net loss per share allocable to common stockholders, diluted: -0.09
Today's EPS Names:
LBIX, ESEA, ISS, More
Financial Fact:
Net loss per share allocable to common stockholders, diluted: -0.09
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade ARNA Now!
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q3 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $3.46 million versus the consensus estimate of $3.37 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Brady Corp. (BRC) Misses Q3 EPS by 5c; Guides Q4 EPS Below Views
- Sina Corp (SINA) Tops Q1 EPS by 5c, Offers Guidance
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
